Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder.

Article Abstract
Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder. [CME]

Joseph Biederman, M.D., opened the symposium by reviewing the history of attention-deficit/hyperactivity disorder (ADHD), neurologic impairment in individuals with ADHD, and the prevalence of the disorder and comorbid conditions. Dr. Biederman also explained how, together, symptoms and comorbid conditions result in the impairments associated with ADHD.

Volume: 64

Quick Links: ADHD , Neurodevelopmental

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF